Special issue on micro-nanomaterials for biomedical applications
Published 02 September, 2021
Recent advances in micro-nanomaterials with designed physiochemical properties offer new opportunities for biomedical imaging and therapy, which include, customised versions of organic materials, such as small molecules and conjugated polymers, along with inorganic materials, such as metal clusters and quantum dots, and their hybrids. Among the diseases benefitting from these developments are neurological diseases, tumours, cardiovascular diseases and bacterial infections. By harvesting their distinctive optical, acoustic, magnetic (and other) properties, these micro-nanomaterials are used to visualise physiological and pathological processes in vivo or in vitro via imaging modalities such as fluorescence, photoacoustic and magnetic resonance imaging, and etc. In addition, the intricate chemistry of the materials paves the ways for therapeutics including phototherapy, chemotherapy, chemodynamic therapy, immunotherapy and combinatory therapy.
This special issue aims to highlight recent advances in the development of micro-nanomaterials applied in the biomedical field. Original research papers, reviews and mini review papers are all welcome.
- The acceleration of wound healing using microscale gel array patches encapsulating BMSCs
Dr. Zhen Xu, Shenzhen University, China. Email: email@example.com
- Porphyrin-containing polymer nanoparticles for bioimaging of cancers
Dr. Bing Guo, Harbin Institute of Technology (Shenzhen), China. Email: firstname.lastname@example.org
- Smart inorganic/organic micro-nanohybrids as theranostic probes
Dr. Ruirui Qiao, The University of Queensland, Australia. Email: email@example.com
- Nanomedicine approaches for protein delivery: current status and future perspectives
Dr. Baozhu Zhang, People’s Hospital of Shenzhen Baoan District, The Second Affiliated Hospital of Shenzhen University, China. Email: firstname.lastname@example.org
- Nanotherapies from an oncologist doctor's view
Dr. Qingwei Meng, Harbin Medical University Cancer Hospital, China. Email: email@example.com
- Publication date: 31 December 2022
Please read the Guide for Authors before submitting. All articles should be submitted online; please select Biomedical applications on submission.
- Dr. Bing Guo, Harbin Institute of Technology (Shenzhen), China. Email: firstname.lastname@example.org
- Dr. Ruirui Qiao, The University of Queensland, Australia. Email: email@example.com